期刊文献+
共找到9篇文章
< 1 >
每页显示 20 50 100
Inhibition of human cytochrome CYP1B1 by anthraquinone compounds,chrysophanol and physcion
1
作者 JIA Liwei ZHOU Lei +3 位作者 WANG Zhenyue WANG Qianbo LIU Xiaoyan MENG Xin 《黑龙江大学自然科学学报》 CAS 2024年第4期427-433,共7页
The in vitro inhibitory effects of chrysophanol and physcion on CYP1B1 were explored,utilizing ethoxyresorufin as the substrate.The inhibition kinetics of CYP1B1 by these compounds were assessed with escalating doses ... The in vitro inhibitory effects of chrysophanol and physcion on CYP1B1 were explored,utilizing ethoxyresorufin as the substrate.The inhibition kinetics of CYP1B1 by these compounds were assessed with escalating doses of ethoxyresorufin.Both chrysophanol(IC_(50)(0.47±0.01)μmol·L^(-1))and physcion(IC_(50)(0.35±0.02)μmol·L^(-1))significantly reduce the catalytic efficiency of CYP1B1.The V_(max)and K_(m)values are determined to be(51.9912±10.0547)pmol·μg^(-1)(protein)·min^(-1) and(0.9663±0.2987)nmol·L^(-1)for chrysophanol,and(45.4227±1.9978)pmol·μg^(-1)(protein)·min^(-1) and(0.4367±0.0386)nmol·L^(-1)for physcion,respectively.Kinetic analysis reveals that chrysophanol and physcion exert mixed inhibitory effects on CYP1B1.This mixed inhibition is primarily characterized by the compounds’ability to competitively bind to the active sites of CYP1B1,as well as potentially through non-competitive mechanisms,thereby reducing the enzyme’s catalytic efficiency.Molecular docking studies are conducted to elucidate the interaction between anthraquinone derivatives and CYP1B1,indicating that these compounds may inhibit CYP1B1 activity by binding to their active sites.The demonstrated capacity of chrysophanol and physcion to inhibit CYP1B1 enzymatic function unveils a potential anticancer mechanism,advancing our comprehension of how the structure of anthraquinone derivatives correlates with CYP1B1 inhibition and paving the way for developing innovative cancer treatments. 展开更多
关键词 CYP1B1 CHRYSOPHANOL PHYSCION anthraquinone derivative enzyme inhibitor
下载PDF
Ab Initio Molecular Dynamics Simulation of Liquid Water with Fragmentbased Quantum Mechanical Approach under Periodic Boundary Conditions
2
作者 Jinfeng Liu Xiao He 《Chinese Journal of Chemical Physics》 SCIE CAS CSCD 2021年第6期761-768,I0002,共9页
In this study,we investigated the structural and dynamical properties of liquid water by using ab initio molecular dynamics simulation under periodic boundary conditions based on the fragment-based quantum mechanical ... In this study,we investigated the structural and dynamical properties of liquid water by using ab initio molecular dynamics simulation under periodic boundary conditions based on the fragment-based quantum mechanical approach.This study was carried out using the second-order Møller-Plesset perturbation theory(MP2)with the aug-cc-pVDZ basis set,which has been validated to be sufficiently accurate for describing water interactions.Diverse properties of liquid water,including radial distribution functions,diffusion coefficient,dipole moment,triplet oxygen-oxygen-oxygen angles,and hydrogen-bond structures,were simulated.This ab initio description leads to these properties in good agreement with experimental observations.This computational approach is general and transferable,providing a comprehensive framework for ab initio predictions of properties of condensed-phase matters. 展开更多
关键词 Ab initio Simulations LIQUID Quantum fragmentation approach
下载PDF
“一带一路”背景下我国与东盟国家仿制药注册制度对比研究 被引量:2
3
作者 颜建周 赵丹 +1 位作者 张晓宇 邵蓉 《中国医药工业杂志》 CAS CSCD 北大核心 2020年第2期284-289,共6页
近年来,在"一带一路"的大背景下我国与东盟国家医药贸易往来不断加大,药品专利到期为仿制药提供了巨大的发展空间。为推动我国与东盟国家仿制药产业的合作发展,保障人民用药可及性,本文通过文献研究对东盟仿制药申请现状进行... 近年来,在"一带一路"的大背景下我国与东盟国家医药贸易往来不断加大,药品专利到期为仿制药提供了巨大的发展空间。为推动我国与东盟国家仿制药产业的合作发展,保障人民用药可及性,本文通过文献研究对东盟仿制药申请现状进行梳理,选取东盟中与我国医药贸易往来较大的3个国家(新加坡、泰国、马来西亚)与我国进行仿制药申请制度的对比,以期为我国与东盟国家展开仿制药产业合作提供有价值的科学信息。 展开更多
关键词 仿制药 注册申请制度 通用技术文件 一致性评价
原文传递
Development and challenges of professional Master of pharmacy education in China 被引量:4
4
作者 Jie Gu Yanli Liu +3 位作者 Fengguo Xu Yongze Zhang Rong Shao Tao Lu 《Journal of Chinese Pharmaceutical Sciences》 CAS CSCD 2021年第1期69-76,共8页
In the present work,we aimed to describe the current situation and developing trend of professional Master of pharmacy education in China.Systematic searches of websites for literatures related to the specialty of pro... In the present work,we aimed to describe the current situation and developing trend of professional Master of pharmacy education in China.Systematic searches of websites for literatures related to the specialty of professional Master of pharmacy were conducted.E-mail or telephone inquires were made directly to 108 pharmacy institutions(schools and universities)in China offering the MPharm program.The MPharm program was established in China in 2010,which primarily focuses on cultivating professionals in fields,such as drug technology transformation,inspection and regulation of drugs,registration and distribution of drugs,and pharmaceutical services.After 9 years of development,it has almost completed the overall design of its higher education paradigm with Chinese characteristics.With the rapid development of the pharmaceutical industry in China,the professional degree of pharmacy education program at the master’s level is insufficient to meet social and market demand for qualified professionals.Therefore,doctoral-level programs are now being promoted. 展开更多
关键词 China Pharmacy education Professional Master of Pharmacy Chinese graduate program
原文传递
Cardioprotective effects of combination of notoginseng total saponins and safflower total flavonoids against myocardial infarction in rats 被引量:5
5
作者 Yuqing Meng Lichao Wang +6 位作者 Yan Li Jinyang Song Zhiyong Du Chun Li Yong Jiang Pengfei Tu Xiaoyu Guo 《Journal of Chinese Pharmaceutical Sciences》 CAS CSCD 2018年第2期116-122,共7页
In this study, the cardioprotective mechanism of the combination of notoginseng total saponins and safflower total flavonoids(CNS) was investigated due to its excellently efficacy against myocardial infarction(MI)... In this study, the cardioprotective mechanism of the combination of notoginseng total saponins and safflower total flavonoids(CNS) was investigated due to its excellently efficacy against myocardial infarction(MI) in rats. After the left anterior descending coronary artery(LADCA) ligation, rats were orally administered with CNS for 7 consecutive days. CNS prevented MI-induced pathophysiological changes and significantly decreased plasma levels of myocardial enzymes, including creatine kinase MB isoenzyme(CK-MB), lactate dehydrogenase(LDH) and aspartate aminotransferase(AST). Further investigation revealed that CNS attenuated the production of inflammatory factors in plasma, including tumor necrosis factor-alpha(TNF-α), interleukin-6(IL-6) and interleukin-1β(IL-1β). Moreover, CNS treatment decreased the expression of caspase-3 at the mR NA level in infarct tissue. Our findings demonstrated that the anti-inflammatory and anti-apoptotic properties of CNS might confer its cardioprotection against MI in rats. 展开更多
关键词 Myocardial infarctions INFLAMMATION APOPTOSIS Notoginseng Radix et Rhizoma Carthami Flos
原文传递
Intranasal delivery of rapid-onset antidepressants:a new trend of treating major depressive disorder
6
作者 Yuqi Xie Yushun Dou Yue Tang 《Journal of Chinese Pharmaceutical Sciences》 CAS CSCD 2020年第8期515-527,共13页
Existing antidepressants seem to have an onset time of several weeks.However,newly found depression-related receptors and pathways may enlighten us to find more rapid-onset antidepressants,in which ketamine is one of ... Existing antidepressants seem to have an onset time of several weeks.However,newly found depression-related receptors and pathways may enlighten us to find more rapid-onset antidepressants,in which ketamine is one of the most potential antidepressants.By intranasal administration,drugs can be directly delivered to the brain via olfactory nerve route,which is proved to be suitable for some antidepressants.Well-designed rapid-onset antidepressants are the urgent requirements of the patients with depression.Intranasal administration,as a potential strategy to deliver antidepressants to brain,can improve drug efficacy and largely shorten the onset time.In this article,we sorted out some new formulation approaches in treating depression with different mechanisms and pathways compared with traditional treating strategies,along with new findings in clinical studies,proving that the combination of rapid-onset antidepressants with intranasal delivery will lead a new trend in treating depression. 展开更多
关键词 Major depressive disorder NMDA receptor Olfactory nerve route Antidepressants INTRANASAL
原文传递
Identification of unknown impurities in triamcinolone acetonide palmitate
7
作者 Xiangfei Jin Minyue Cheng +2 位作者 Sihui Zhong Yungen Xu Weiyang Shen 《Journal of Chinese Pharmaceutical Sciences》 CAS CSCD 2022年第4期270-278,共9页
In the present study,we analyzed the structures of the two unknown impurities that were contained more than 0.1% in triamcinolone acetonide palmitate by using HPLC-DAD and HPLC-MS hyphenated techniques,and these impur... In the present study,we analyzed the structures of the two unknown impurities that were contained more than 0.1% in triamcinolone acetonide palmitate by using HPLC-DAD and HPLC-MS hyphenated techniques,and these impurities were synthesized and purified by column chromatography.Based on the results of NMR spectroscopy,IR spectroscopy,and MS,the two impurities were confirmed as 9-fluoro-11β,21-dihydroxy-16α,17-(isopropylidenedioxy)pregna-1,4-diene-3,20-dione 21-myristate and stearate,respectively. 展开更多
关键词 Triamcinolone acetonide palmitate Impurity identification HPLC-DAD LC-MS
原文传递
Discovery of novel aspartate derivatives as highly potent and selective FXIa inhibitors
8
作者 Ling Zhang Wei Chen +5 位作者 Ningning Yao Shuzeng Hou Zhiwei Meng Yi Kong Chenzhong Liao Zhouling Xie 《Journal of Chinese Pharmaceutical Sciences》 CAS CSCD 2022年第10期727-737,共11页
As a coagulation factor in the intrinsic coagulation pathway,factor XIa(FXIa)is an effective and safe target for the development of antithrombotic drugs.Many small-molecule FXIa inhibitors have been discovered,some of... As a coagulation factor in the intrinsic coagulation pathway,factor XIa(FXIa)is an effective and safe target for the development of antithrombotic drugs.Many small-molecule FXIa inhibitors have been discovered,some of which are being evaluated in clinical trials.However,none of them have been approved.In the present study,a highly selective potent FXIa inhibitor with poor solubility reported in our previous work was selected as a lead compound to be further modified to improve FXIa potency and physicochemical properties.The structure-based drug design and structure-activity relationship study led to the discovery of LY8,LY17,and LY25,which demonstrated enhanced FXIa potency and maintained excellent selectivity.In addition,LY8 exhibited significantly improved aqueous solubility,suggesting that it could be a promising compound to be further evaluated. 展开更多
关键词 ANTITHROMBOSIS ANTICOAGULANTS Factor XIa Bleeding risk Structure-activity relationship
原文传递
Preclinical efficacy of a novel cyclin-dependent kinase 9 inhibitor,QHRD107 against acute myeloid leukemia
9
作者 Yan Zhou Hengwen Song +4 位作者 Zhichao Shao Bomin Yin Ximei Fu Dianyou Xie Lijun Wei 《Journal of Chinese Pharmaceutical Sciences》 CAS CSCD 2021年第2期146-156,共11页
QHRD107 is a specific inhibitor of cyclin-dependent kinase 9(CDK9).It is a highly potent antiproliferative agent against leukemia cells in vitro.Oral administration of QHRD107 to mice bearing acute myeloid leukemia tu... QHRD107 is a specific inhibitor of cyclin-dependent kinase 9(CDK9).It is a highly potent antiproliferative agent against leukemia cells in vitro.Oral administration of QHRD107 to mice bearing acute myeloid leukemia tumors markedly inhibited tumor growth.In Molm-13 orthotopic model,QHRD107 resulted in remarkable prolongation of animal life span.After single oral administration of QHRD107 to Molm-13 xenograft model,QHRD107 was quickly absorbed and distributed to tumor with high concentration within 1 h.Tumor half-life time(T1/2)was three times longer compared with that of plasma.Under the high exposure of QHRD107 in tumor tissue,fast down-regulation of anti-apoptotic protein Mcl-1 mRNA was noted.Reduction of Ki-67 staining in tumor tissue further demonstrated the apoptosis of tumor cells.Therefore,the results provided evidence that QHRD107 at therapeutic dose had significant antitumor activity against AML cell lines. 展开更多
关键词 QHRD107 CDK9 inhibitor EFFICACY PHARMACOKINETICS
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部